Aktie A007460 APROGEN MEDICINES INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Aprogen Medicines Inc.

Aktien

A007460

KR7007460009

A007460

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 28.06.2024 		% 5 Tage % 1. Jan.
1.118 KRW +2,29 % Intraday Chart für Aprogen Medicines Inc. +5,97 % +16,46 %
14.05. Aprogen Medicines Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
19.03. Aprogen Medicines Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Aprogen Medicines Inc. announced that it has received KRW 5.5 billion in funding
Aprogen Medicines Inc. announced that it expects to receive KRW 5.5 billion in funding
Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding
Aprogen Medicines Inc. announced that it expects to receive KRW 70 billion in funding
Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.
Aprogen Medicines Inc. completed the acquisition of remaining unknown stake in Aprogen, Inc.
Aprogen Medicines Inc. signed a merger contract to acquire remaining unknown stake in Aprogen, Inc.
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.
Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.
Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..
Aprogen KIC Inc. announced that it expects to receive KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.
Aprogen KIC Inc. announced that it has received KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A007460 Aktie
  4. Nachrichten Aprogen Medicines Inc.
  5. Andere Sprachen